Drug Shortage Report for CARBOPLATIN INJECTION
| Report ID | 135135 |
| Drug Identification Number | 02125439 |
| Brand name | CARBOPLATIN INJECTION |
| Common or Proper name | CARBOPLATIN INJECTION 10MG/ML |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | CARBOPLATIN |
| Strength(s) | 10MG |
| Dosage form(s) | LIQUID |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 60ml |
| ATC code | L01XA |
| ATC description | OTHER ANTINEOPLASTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2021-03-03 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2021-04-29 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2021-04-29 | French | Compare |
| v3 | 2021-04-29 | English | Compare |
| v2 | 2021-03-04 | French | Compare |
| v1 | 2021-03-04 | English | Compare |
Showing 1 to 4 of 4